This evening we got alerted by our system that the Executive Chairman, President & CEO of Intrepid Potash, Inc. (ticker: IPI) bought 50,000 shares of his own company. Jornayvaz Robert P III paid an average of $2.30 per share. Earlier this year, on the 21st of March he also bought IPI shares and since then the stock price has nearly doubled. This guy certainly seems to time his insider purchases right.
We think that this is a very interesting insider buy and we picked up shares immediately. It seems that there is some serious resistance sitting at the $2.50 mark, but this insider buy could potentially push the stock through this multiple top. We are hoping to make a quick 8% profit here and we’ve set our closing order at just below $2.50. If it manages to push through the resistance at $2.50 it has large potential to go a lot of higher because there are currently a lot of people shorting this stock who will need to close their positions then.
What does Intrepid Potash, Inc. do?
Intrepid Potash, Inc. produces and sells potash and langbeinite products in the United States and internationally. It operates in two segments, Potash and Trio. The Potash segment offers muriate of potash or potassium chloride for use as a fertilizer input in the agricultural market; as a component in drilling and fracturing fluids for oil and gas wells, as well as an input to other industrial processes in the industrial market; and as a nutrient supplement in the animal feed market. The Trio segment provides Trio, a specialty fertilizer that combines potassium, sulfate, and magnesium in a single particle. The company also offers salt for use in animal feed, pool salt, road and walkway treatment, and other industrial applications; magnesium chloride for use in the deicing and dedusting of roads; salt and potassium brines for well development and completion applications in the oil and gas industry; and metal recovery salt, a combination of potash and salt to enhance the recovery of aluminum in the aluminum recycling processing facilities. Intrepid Potash, Inc. was incorporated in 2007 and is based in Denver, Colorado.
- Published in Basic Materials
Today in the early morning at 9.56am our system alerted us of a large insider buy in FORM Holdings Corp. Their director Richard Abbe picked up 39,670 shares on Friday, May 19th. He paid an average of 1.54 per share, making a total investment of $61,139. The stock jumped up today and we could have grabbed a quick and easy profit, but did we?
As you can see on the screenshot below, the insider buy of today is not the only insider trade over the last days. However, our system did not alert us of the other buys due to the small value size. The stock had gone up already a little bit on the news of the multiple smaller insider buys and therefore we did not pick up any shares this time. Learning of the day: Once again it shows us that we should keep emotions out of the game and just trust our system. More than 80% of our alerts make us quick and easy profits so we should just stick with playing the numbers game.
More information about FORM Holdings Corp.
FORM Holdings Corp., together with its subsidiaries, develops, acquires, and monetizes intellectual property worldwide. It operates through three segments: Intellectual Property, Fli Charge, and Group Mobile. The company’s intellectual property portfolio consists of approximately 600 patents and patent applications covering telecom infrastructure, Internet search, ad-insertion, and mobile technologies. It also designs, develops, licenses, manufactures, and markets wire-free conductive power and charging solutions, such as conductive charging pads and associated cases for phones, tablets, and laptops. In addition, the company operates as a full service reseller of rugged computers, rugged tablets, rugged mobile devices, rugged mobile printers, vehicle computer docking and mounting gears, power accessories, wireless communication products, antennas, carrying cases, peripherals, and accessories, and other related products to emergency first responders, municipalities, and corporations. The company was formerly known as Vringo, Inc. and changed its name to FORM Holdings Corp. in May 2016. FORM Holdings Corp. is based in New York, New York.
- Published in Technology
In April our algorithm picked up a significant insider buy in Oramed Pharmaceuticals Inc.: Li Xiaopeng, a Director of the company, bought 52,814 shares worth 334,313 dollars that day. The price? $6.33. Today ORMP is listed at $8.48… This represents a gain of +32% from the April 19 alert. If you had sold it on April 26, just 1 week (!!!) after the insider trading alert, you would have a quick profit of 40% in your pocket as you can see on the screenshot below.
A +40% gain…Li Xiaopeng knows what he is doing and he timed his buy perfectly! The reason why the stock went up and is still going up further is because ORMP received patents in multiple continents for their new drug. I received a few e-mails in my personal mailbox about the ORMP insider buying alert and some subscribers made a lot of money here. Although I would advise everyone to stay methodical, I am happy that many made huge financial strides on this trade (and that some take the time to write these delightful notes)!
More information on Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Its product portfolio includes ORMD-0801, an oral insulin capsule, which has completed Phase IIb clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which has completed Phase Ib clinical trials for the treatment of type 2 diabetes. The company operates primarily in Israel. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in Jerusalem, Israel.
- Published in Biotech
Recently I have been asked more and more about what Stockspikes.com really brings to the table. About what our mission and our vision is. About how we are different or how we can make a difference in a world filled to the rim with gurus, “professionals”, advisers, consultants, websites, etc. Private equity firms and angel investors have taken notice of Stockspikes.com and our approach and wanted to talk shop. Needless to say, we are not interested in creating a Fortune 500 company or taking money from wolves who will then tell us how to run our business. Nevertheless, the story I tell them is borrowed from a book or movie you will all recognize.
Stockspikes.com and Moneyball
A few weeks ago I watched one of my favorite movies again: Moneyball (2011). If you have not seen it yet, it is an unbelievable film adapted from an even better book published in 2003. ‘Moneyball: The Art of Winning an Unfair Game’ is a book by Michael Lewis about the Oakland Athletics baseball team. It walks you through how the team overcame adversity and its disadvantaged revenue situation (vs. the New York Yankees for example) by analytically selecting players for their baseball team based on specific statistics. Although he seriously stepped on the fragile toes of conventional baseball wisdom in the process, the Oakland A’s general manager, Billy Beane, managed to put together a competitive team in comparison to much wealthier teams. Well, Stockspikes.com plays stock market Moneyball by following Legal Insider Buying Activity.
Stockspikes in the Major League Stock Market
There are many ‘teams’ out there who play traditional ball on the stock market. All the investment banks like Goldman Sachs, JP Morgan, Morgan Stanley, etc. and traditional investors like Warren Buffet, George Soros, etc. They are the rich teams. One of the quotes of the movie that always stuck with me was: “If we play like the Yankees in here (referring to the scouting team’s meeting), we will lose to the Yankees out there (referring to future match-ups with rich teams).” Many of the investment banks and gurus have what you do not have yet: millions or never mind billions. Because of that huge pile of cash they have, they can play the stock market game in a traditional way. With big ticket slow moving stocks and lots of time/patience.
5% in a big stock can often take a while, but if you put in 100 million dollars you get 5 million dollars profit. Nice. Do you have 100 million dollars? The Oakland Athletics did not either. The baseball team also needed to get ready, they could not wait 30 years to become competitive. So how do you play the game with 50K, 10K, 1K? You play stock market moneyball. You find cheap stocks with key statistics that predict theoretical performance. Why would you not? The information is available out there and like Jonah Hill’s character in Moneyball, Stockspikes wrote an algorithm to automate the scouting process. We find relevant, high potential insider buys and take action in the same stocks. It’s safe, reliable, and fast.
At the end of the movie after the play-offs, Billy Beane gets a call from the Boston Red Sox. They offer him an extremely attractive job offer, but he declined and stayed with the Oakland Athletics. I have no interest in becoming affiliated with any huge investment bank. Stockspikes.com will always remain independent. Although I will never be nominated for an Academy Award as Best Actor in a Leading Role, I hope you understand now why Stockspikes.com does what it does. If you want to get the same alerts that land in our mailbox and the one from our premium subscribers automatically, subscribe for a Free Trial.
- Published in General
On Wednesday the 12th of April, 2017, the Chairman & CEO of Agenus Inc. picked up shares in his own company. He made two large buys with a total value of $330,000 over the past couple of days according to the filing (filing 1 & filing 2). Our system alerted us yesterday after market close of this insider trade.
What’s our take on this trade?
When we look at the chart of $AGEN we notice one thing that worries us. The stock recently dropped through a multiple bottom, which is usually a very negative sign. Overall, it seems to be trending down very clearly since October last year. On the other hand, our system didn’t alert us for no reason. It is a double insider purchase from a good insider. He has purchased more shares in the past and most of the time the stock went up afterwards. Furthermore, we see a good amount of volume of this stock so we don’t have to worry about not being able to sell shares if it isn’t going to be a success. The low average volatility worries us a little bit, but still we feel that it is worth a shot. We are buying and hoping to get a quick profit of around 8% to 10%. At the same time we will set a stop loss at $3.00 and will keep an eye at this trade. If it doesn’t go up in the coming days, close your position and move on to the next trade.
More information on Agenus Inc.
Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body’s immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; SECANT yeast display, an antibody discovery platform used for the generation of novel monoclonal antibodies; and phage display technologies. It is also developing checkpoint modulating antibody candidates targeting GITR, OX40, TIM-3, and LAG-3. In addition, the company develops vaccine programs, such as Prophage cancer vaccine candidate; AutoSynVax, a synthetic cancer vaccine program targeting the neo-epitope landscape in cancer patients; and PhosPhoSynVax, a vaccine candidate designed to induce immunity against a novel class of tumor specific neo-epitopes. Further, Agenus Inc. develops QS-21 Stimulon, a saponin-based vaccine adjuvant that has completed Phase III clinical trials for the treatment of malaria and shingles. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
- Published in Biotech
February was a big month for the stock market as a whole, but BIGGER for us.
Although the S&P 500 index is setting a new all-time high record and the Nasdaq keeps pushing higher and higher, legal insider buying transactions are pushing the limits of what is possible.
Here is a quick overview of what some of our recent alerts did in one daytoday:
Unfortunately not too many people have profited from this amazing rally … Even with the markets going up, most of the investors are still losing money.
The NUMBER ONE REASON for this is the lack of time to research the market and pick the right stocks. That we can solve, however!
As you probably know, our way of investing is very simple. Whenever an insider buys a significant amount of shares of its own company, we buy as well. We usually sell within the following month, making quick, juicy returns.
Do we follow all insider buying activity? No, definitely not, only the ones that meet all of our criteria. Since we have started trading insider buys many years ago, we have a hit rate of 80%.
Does this mean that 80% of our picks are winners? Yes it certainly does!
And it gets even better, a lot of our picks gain more than 10% within one month after the alert. Double your portfolio in 2014 like we do every year since we started.
It is impossible for us to lie about the performance of our alerts, as we report insider buying activity as it is legally filed.
So what are you waiting for? Just sign up for a 14 day free trial and check it out. It is a regular Credit Card subscription for 0 dollars for the first 14 days and you can cancel any time!
- Published in General
January! A time when I always get giddy about the coming year, although market analysts are wetting their panties for what is to come. Supposedly, it will be a very volatile year and indices will not end up much higher. Who cares :). Volatility is a good thing for insider buying and we do not really care about the overall market anyway. We like inside buying!
January is a slow month. Not only traditionally, but we think the big investment banks might have scared some of the insiders off too. Every year it is the same story: market this, market that, bla bla bla. Did you know that almost every investment bank said that the market would go up by 10 percent last year? Well, it didn’t. It went up a lot higher. It could have tanked for all we know. No one can predict the future. We can’t either!
The difference however, is that we are not actively trying to bite of more than we can chew. We are not out there analyzing the effects of the Fed’s tapering on the overall market or China’s impact on the gold price and how everything ties together. Even when your analysis makes sense, it has no predictive power. None. Whatsoever. Statistically proven.
What we did do, is look at what statistics did prove. The fact that legal insider buying activity is often associated with a stock price increase for example. If there are people with some predictive power in our opinion, they are the people leading the individual companies on the stock market. Does the stock price always go up after an insider buy takes place? No. Does it often go up? Yes. Especially with some of the criteria that we add to the mix. Every day a lot of insider buying activity happens, but that event might not have an impact on a stock like IBM for example. So we do not report it in our Premium E-mail Alerts.
This week Seacoast Banking Corp ($SBCF) provided us with another nice bump to add to the mix!
Will every month be a killer month? No. Will over time, the returns of this strategy outperform the returns of the market and reliably get me to move the needle for your capital. Yes. Very much so! For newcomers to our community, check out our monthly reports, check out our blog posts. This is all verifiable information. We hide nothing, because there is nothing to hide. If an insider buys and the stock fits our criteria, it lands in our Premium Alerts Subscriber’s inbox. Boom. Done. Next!
- Published in General
Although both stocks posted decent highs inside May of +8.45% and +19.35% respectively, June was really where the action was about to happen. Let’s take another look at Limelight Networks (LLNW) and Geron Corporation (GERN) to make clear what insider buying activity is all about. Stock prices do not really care about dates as much as people do as you can see below.
BOOM! +41% on LLNW and +69% on GERN! See what I mean here? This is the kind of information you miss when only looking at snapshots. +41% and +69% from the time of our alerts looks completely different figures than what we saw in May alone, of course.
So what happened here? Well in short LLNW won an 8-year old patent infringement court case in early June, and the FDA removed the hold on GERN’s cancer research clinical trial in the middle of June. We first alerted LLNW on May 22nd and GERN on May 12th in real-time at $2.13 and $1.86 respectively when significant insider buying had just taken place in both companies.
For new readers: this is the kind of price action you get when following insider buying activity. So many statistical studies have proven the edge insiders have and, as a consequence, investors who follow them closely (that is why we do it in real-time) and on top of that there are plenty of anecdotal stories like the above that underline that insiders do know more.
Because this is not the millionth profitable coincidence, of course, and you can bet your pinky that these things will keep happening with a lot of stocks spiking as a result. From our perspective we just let it all happen and we are going to keep profiting from this happily and safely. Sign up for a Free Trial by clicking the button below if you have not already!
Boom!! As the whole market was enveloped in a pathetic week, insiders brought their game again. Another +10% jump on the books and congrats to our Premium Subscribers once again! This is The Definition of Insider Trading.
The Definition of Insider Trading
In short, we had a repeat of Week #4 in the world of insiders. If you follow insider buying behavior, you know that since the beginning of time, insider buying is correlated with jumps in the stock price. CEOs know more about their company than any other person and when they buy stock of their own company (legally), the market at least assumes something is up, and if it is, the stock spikes. Simple as that. It has been proven time and time again in statistical studies that our strategy works.
As most of our subscribers know, we actually love this strategy mostly because it is safe as you are protected to the downside because of market expectations. Next to that, you get a lot of short term jumps to profit from! This week we had two alerts displaying just that with $SANW and $UTSI popping up in our and our premium subscriber’s inboxes on Tuesday and Wednesday. For people who want to get these alerts, you have access to a 14 day free trial and you can cancel any time.
$UTSI did not move around much and we signed off with a 0.5% loss there. For new people reading this, this is great news. No stock market strategy gets a winner every time. Not a single one. The difference is that we barely lose any money on the non-performers. You will notice that the stock did not tank. It just did not move around much as we are protected by the expectations of the market. Then we had $SANW, which booked us a +10% jump in a few days! This is the definition of what we do: statistically proven, protected by market expectations, quick in and out, high percentage of winners. Once again, I am not claiming that we are better than anybody else. But we do have the key to regularly participating in strong short-term gains safely and reliably.